Cargando…
A new KIF5B–ERBB4 gene fusion in a lung adenocarcinoma patient
ERBB4 fusion is a rare, novel oncogenic event involved in the development of lung adenocarcinoma that is not routinely looked for, although ERBB4 fusion is a potential target for existing pan-ErbB tyrosine kinase and must be implemented in the laboratory https://bit.ly/3nYmGQ9
Autores principales: | Guenzi, Edouard, Pluvy, Johan, Guyard, Alice, Nguenang, Marina, Rebah, Khedidja, Benrahmoune, Zoubida, Lamoril, Jérome, Cazes, Aurelie, Gounant, Valérie, Brosseau, Solenn, Boileau, Catherine, Zalcman, Gérard, Théou-Anton, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005686/ https://www.ncbi.nlm.nih.gov/pubmed/33816604 http://dx.doi.org/10.1183/23120541.00582-2020 |
Ejemplares similares
-
Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors
por: Bouchez, Clémentine, et al.
Publicado: (2020) -
Detection of Nine Oncogenes Amplification in Lung and Colorectal Cancer Formalin-Fixed Paraffin-Embedded Tissue Samples using Combined Next-Generation Sequencing-Based Script and Digital Droplet Polymerase Chain Reaction
por: Bontoux, Christophe, et al.
Publicado: (2023) -
Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report
por: Pluvy, Johan, et al.
Publicado: (2019) -
Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment
por: Gounant, Valérie, et al.
Publicado: (2021) -
Transthoracic lung biopsy for pulmonary nodules ≤20 mm in routine clinical care
por: Lissavalid, Emilie, et al.
Publicado: (2022)